Stubborn liver cancer may have met its match in century-old TB vaccine
The 102-year-old tuberculosis vaccine shrunk liver cancer tumors in mice, which suggests it may be replicated in a human trial. If this was the case, the vaccine might prove successful in tackling this notoriously hard-to-treat cancer. Source of Article